ATLANTA, GA--(Marketwire - February 01, 2008) - AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its fourth quarter and year-end 2007 financial results on Thursday, February 14, 2008 before the U.S. financial markets open.
